Evidence map›Paper›PMID 36556017›Full record

ArticleJournal of clinical medicine2022

Effect of Folic Acid Treatment for Patients with Traumatic Brain Injury (TBI)-Related Hospital Acquired Pneumonia (HAP): A Retrospective Cohort Study.

Hao Wu, Xin Geng, Chenan Liu, Augustine K Ballah, Feixiang Li, Tangrui Han, Shuai Gao, Chunhong Wang, Hongming Ji, Xiaoqi Nie and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Hao WuDepartment of Neurosurgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China.ORCID 0000-0002-3814-315X
Xin GengDepartment of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.ORCID 0000-0002-7112-1526
Chenan LiuKey Laboratory of Cancer FSMP for State Market Regulation, Beijing 100038, China.
Augustine K BallahDepartment of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.ORCID 0000-0003-1080-7417
Feixiang LiDepartment of Neurosurgery, The First Affiliated Hospital of Shanxi University, Taiyuan 030001, China.
Tangrui HanDepartment of Neurosurgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China.
Shuai GaoDepartment of Neurosurgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China.
Chunhong WangDepartment of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan 030012, China.
Hongming JiDepartment of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan 030012, China.
Xiaoqi NieDepartment of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan 030012, China.
Gang ChengDepartment of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan 030012, China.
Xiangyu WangDepartment of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.ORCID 0000-0001-5103-433X
Rui ChengDepartment of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan 030012, China.
Yonghong WangDepartment of Neurosurgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China.
Shanxi Medical University · CNFirst Affiliated Hospital of Jinan University · CNCapital Medical University · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital Acquired Pneumonia (HAP) is one of the most common complications and late causes of death in TBI patients. Targeted prevention and treatment of HAP are of great significance for improving the prognosis of TBI patients. In the previous clinical observation, we found that folic acid treatment for TBI patients has a good effect on preventing and treating HAP. We conducted this retrospective cohort study to demonstrate what we observed by selecting 293 TBI patients from two medical centers and analyzing their hospitalization data. The result showed that the incidence of HAP was significantly lower in TBI patients who received folic acid treatment (44.1% vs. 63.0%,

Indexed as

folic acidHospital Acquired Pneumoniatraumatic brain injury

Identifiers

PMID36556017
PMCPMC9783303
OpenAlexW4311393067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.